Welcome to our dedicated page for Modivcare SEC filings (Ticker: MODV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Reading Modivcare’s disclosures can feel like navigating three businesses at once: non-emergency medical transportation contracts, personal care margins, and remote patient monitoring growth. Buried across a 300-page annual report and dozens of 8-K updates are critical details on state Medicaid renewals, driver labor costs, and technology investments that move the stock.
Stock Titan’s AI-powered analysis turns that complexity into clarity. Need the latest Modivcare quarterly earnings report 10-Q filing? Our platform tags revenue by segment, flags contract wins, and answers the natural question, “What changed this quarter?� Looking for Modivcare insider trading Form 4 transactions? We stream Modivcare Form 4 insider transactions real-time and summarize buying or selling trends so you can monitor sentiment before material events.
Every filing type is covered the moment it hits EDGAR:
- 10-K � see a Modivcare annual report 10-K simplified with AI-generated risk overviews.
- 10-Q � drill into quarter-over-quarter transportation volumes with our Modivcare earnings report filing analysis.
- 8-K � get Modivcare 8-K material events explained in plain English within minutes.
- Form 4 � track Modivcare executive stock transactions Form 4 alongside historical patterns.
- Proxy 14A � review Modivcare proxy statement executive compensation without combing through tables.
Whether you’re comparing RPM adoption trends or verifying cash-flow guidance, our real-time alerts, expert notes, and plain-language summaries mean Modivcare SEC filings explained simply. Stop scrolling, start understanding�understanding Modivcare SEC documents with AI begins here.
ModivCare Inc. (MODV) commenced voluntary Chapter 11 cases on August 20, 2025, and entered a Restructuring Support Agreement with consenting first‑lien lenders and second‑lien noteholders to implement a court‑supervised recapitalization. The RSA contemplates $100 million of debtor‑in‑possession (DIP) financing, up to $300 million of takeback term loans at emergence, conversion of approximately $871 million of first‑lien claims into $200 million of exit debt plus ~98% pro forma equity, and conversion of ~ $316 million of second‑lien claims into ~2% pro forma equity. The plan also contemplates new warrants, a potential $200 million equity rights offering, and a $250 million revolving facility. The restructuring would reduce funded debt by about $1.1 billion. The company continues as debtor‑in‑possession, has requested customary "first day" relief, and cautions that common stockholders may suffer significant or complete loss.
ModivCare Inc. notified the SEC that it cannot timely file its Quarterly Report for the quarter ended June 30, 2025 because it needs more time to complete a goodwill impairment assessment and to finish an outside-counsel investigation, directed by the Audit Committee, into compliance hotline allegations including matters related to the company’s culture. The company says these matters are material to its consolidated interim financial statements.
ModivCare also warns that consolidated revenue, EBITDA and Adjusted EBITDA for the quarter are expected to be significantly lower versus the prior-year period, driven in part by an expected goodwill impairment of not less than $250 million, which could be larger as the assessment continues.
FAQ
What is the current stock price of Modivcare (MODV)?
What is the market cap of Modivcare (MODV)?
